|1.||Linnebank, Michael: 4 articles (01/2014 - 10/2005)|
|2.||Li, Yong: 4 articles (06/2009 - 03/2004)|
|3.||Guéant, Jean-Louis: 4 articles (01/2008 - 09/2003)|
|4.||Simon, Matthias: 3 articles (01/2014 - 11/2006)|
|5.||Semmler, Alexander: 3 articles (01/2014 - 11/2006)|
|6.||Sfaxi, Mohamed: 3 articles (02/2011 - 07/2007)|
|7.||Ouerhani, Slah: 3 articles (02/2011 - 07/2007)|
|8.||Marrakchi, Raja: 3 articles (02/2011 - 07/2007)|
|9.||Chebil, Mohamed: 3 articles (02/2011 - 07/2007)|
|10.||Zhu, Wen-li: 3 articles (06/2009 - 06/2004)|
01/01/2014 - "Molecular modeling studies and synthesis of novel methyl 2-(2-(4-oxo-3-aryl-3,4-dihydroquinazolin-2-ylthio)acetamido)alkanoates with potential anti-cancer activity as inhibitors for methionine synthase."
01/01/2014 - "The methionine synthase variant c.2756A>G is associated with various types of cancer. "
03/01/2010 - "Methionine synthase A2756G polymorphism and cancer risk: a meta-analysis."
08/01/2002 - "Second, tumors occurring in homozygous carriers of the methionine synthase 2756G allele show a lower number of hypermethylated CpG islands of tumor suppressor genes (P = 0.029). "
01/01/1981 - "On the 8th day after transplantation the methionine synthetase activity and proliferative pool of tumor cells were estimated. "
|2.||Colorectal Neoplasms (Colorectal Cancer)
12/01/2004 - "Colorectal cancer and the methylenetetrahydrofolate reductase 677C -> T and methionine synthase 2756A -> G polymorphisms: a study of 2,168 case-control pairs from the JANUS cohort."
12/01/2006 - "Also, none of the SNPs were associated with risk in subgroups of dietary methyl status or were jointly associated with colorectal cancer risk in combination with another SNP, except possibly SNPs in methionine synthase and transcobalamin II. However, these analyses of gene-diet interactions were limited in statistical power. "
12/01/2004 - "We evaluated the relation between the polymorphisms 677C --> T of the methylenetetrahydrofolate reductase (MTHFR) and 2756A --> G of the methionine synthase (MTR) genes and risk of colorectal cancer. "
01/01/2012 - "The polymorphisms in methylenetetrahydrofolate reductase, methionine synthase, methionine synthase reductase, and the risk of colorectal cancer."
09/01/1999 - "A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk."
|3.||Neural Tube Defects (Exencephaly)
05/10/2013 - "Many studies have accessed the association between methionine synthase (MTR) A2756G polymorphism and neural tube defect (NTD). "
05/10/2013 - "Association between the methionine synthase A2756G polymorphism and neural tube defect risk: a meta-analysis."
09/01/2010 - "Methionine synthase polymorphisms (MTR 2756 A>G and MTR 2758 C>G) frequencies and distribution in the Jordanian population and their correlation with neural tube defects in the population of the northern part of Jordan."
11/01/2000 - "[Methionine synthase and neural tube defects]."
08/01/1999 - "Methionine synthase: high-resolution mapping of the human gene and evaluation as a candidate locus for neural tube defects."
|4.||Breast Neoplasms (Breast Cancer)
10/01/2013 - "The objectives of this study were to determine the frequency of methyltetrahydrofolate-homocysteine methyltransferase (MTR) 2756 gene polymorphism in patients with breast cancer. "
10/01/2013 - "Role of polymorphism of methyltetrahydrofolate-homocysteine methyltransferase (MTR) A2756G and breast cancer risk."
09/25/2013 - "The methionine synthase (MTR) gene polymorphism A2756G has been linked to the risk of developing breast cancer, but the available results were inconsistent and underpowered. "
09/25/2013 - "Methionine synthase A2756G polymorphism and breast cancer risk: an up-to-date meta-analysis."
08/01/2010 - "The A2756G polymorphism in the methionine synthase (MTR) gene has been implicated in breast cancer risk. "
12/01/1998 - "We also examined the relationship of a newly identified polymorphism (asp919gly) of the methionine synthase gene (MS) with the risk of colorectal adenomas in the same population. "
01/01/2013 - "Methionine synthase A2756G polymorphism and risk of colorectal adenoma and cancer: evidence based on 27 studies."
10/01/2012 - "Methionine synthase and thymidylate synthase gene polymorphisms and colorectal adenoma risk: the self defense forces study."
01/01/2009 - "Methionine synthase A2756G polymorphism interacts with alcohol and folate intake to influence the risk of colorectal adenoma."
01/01/2004 - "Methionine synthase D919G polymorphism, folate metabolism, and colorectal adenoma risk."
|1.||Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)
|3.||methionine synthase reductase
|4.||Folic Acid (Vitamin M)
|9.||Cystathionine beta-Synthase (Serine Sulfhydrase)
|2.||Drug Therapy (Chemotherapy)
|4.||Transplantation (Transplant Recipients)